Effect of OC000459 on Moderate to Severe Atopic Dermatitis
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether OC000459 is in reducing disease severity
and preventing flares in people with moderate to severe atopic dermatitis (AD).